Is telehealth at a crossroads? CMS recently released its 2025 Medicare Physician Fee Schedule, which introduces modest updates to digital health policies, including new codes for FDA-cleared digital mental health therapeutics. CMS made audio-only telehealth services permanent but declined broader changes, such as alternative payment methods for telehealth in rural clinics, citing its limited regulatory authority. Many telehealth flexibilities created at the beginning of the pandemic will expire by the end of 2024 unless Congress intervenes, highlighting the need for legislative action to sustain expanded telehealth access. https://lnkd.in/e8cgp9HA #telehealth #telemedicine #digitalhealth #medicarepolicy #cms
MEDA Ventures
Venture Capital and Private Equity Principals
Washington, D.C. 1,300 followers
Physician & scientist-founded healthcare venture capital group.
About us
We are a physician- and scientist-founded healthcare venture capital group, investing broadly across sectors at the Seed & Series A stages. MEDA Ventures rests on the investment activities of its legacy Fund & broader investment portfolio (22 companies, 2 exits, 0 shutdowns since 2019, as of 6/2024).
- Website
-
https://www.meda.vc
External link for MEDA Ventures
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- Washington, D.C.
- Type
- Partnership
- Founded
- 2019
- Specialties
- Venture Capital, Angel Investing, Healthcare, Medical Devices, Digital Health, Therapeutics, Diagnostics, and Life Sciences
Locations
-
Primary
Get directions
Washington, D.C. 20007, US
Employees at MEDA Ventures
-
Carolyn Campbell
Global C-Suite Executive ◆ Board Member ◆ Finance & Audit ◆ Governance ◆ ESG ◆ Strategy ◆ Operations ◆ Investments ◆ M&A ◆ Cultural Cohesion
-
Elizabeth Cho-Fertikh
Managing Partner, MEDA Ventures
-
Tomas J. Philipson, Ph.D
Founder, Board Member, Former Acting Chairman of the White House Council of Economic Advisers, Chaired Professor Emeritus - University of Chicago
-
Mark LiBassi
Senior Attending Surgeon - St. Mary Medical Center
Updates
-
MEDA Ventures reposted this
Founder, Board Member, Former Acting Chairman of the White House Council of Economic Advisers, Chaired Professor Emeritus - University of Chicago
The economy came out as the most important driver of the US election
-
-
Google Cloud recently launched its Vertex AI Search for Healthcare platform, which builds on and integrates with its prior healthcare LLM offerings (MedLM and Gemini Flash) to ease clinical administrative burden. Its capabilities will streamline providers’ interaction with the EHR, summarizing patient histories and collating relevant diagnostic data at a glance. Early adopters have attributed up time savings of up to 7 minutes per patient to Vertex AI, which furthermore features a decreased hallucination rate compared to legacy models. Read more about Vertex AI Search here: https://lnkd.in/gEwYWYdB #generativeai #healthtech #artificialintelligence #googlecloud Elizabeth Cho-Fertikh Tomas J. Philipson, Ph.D Carolyn Campbell Min Lang Tai Mai Laura Beken
Google’s AI-backed healthcare search tool now available for general use
healthcaredive.com
-
Alongside 10 of the most active US angel investor groups, we are super pleased to have an early look at startups supported by #PlugandPlayTechCenter, one of the largest innovation centers, present in 50+ locations globally.
📣 We are thrilled to collaborate with New York Angels for a first-ever Angel Group Pitch Session with 11 of the country’s largest angel groups! 💡 Welcoming Plug and Play Tech Center batch startups across Plug and Play Fintech, Plug and Play Insurtech, Plug and Play Enterprise & AI, Plug and Play New Materials & Packaging, Plug and Play Agtech & Animal Health, Plug and Play Energy, and more, this session will allow startups to pitch their innovations for the chance of investment. ⚡ We will welcome the following groups to join the session: New York Angels Band of Angels Golden Seeds Miami Angels New World Angels Robinhood Ventures Park City Angels TCA Venture Group Bridge Angel Investors NuFund Venture Group MEDA Ventures ✅ If you are involved with any of these groups and are interested in joining, please reach out for additional information! Doug Pearson Alyssa T. Shirley Li Tabitha Mills #angelinvestors #pnptc #newyorkangels #investment #startupinnovations #ai #foodandbeverage #foodtech #sustainability #health #medtech #insurtech #fintech
-
-
MEDA Ventures reposted this
Behind every placard is a story. At tonight's Major League Baseball (MLB) #WorldSeries game presented by Capital One, we stood united in the fight against cancer. 🧡 Thank you to everyone who participated in this special #StandUpToCancer moment on the field, in the stadium, or at home. Help keep the momentum going by donating to support cancer research that's focused on saving lives now at https://lnkd.in/gayeAkN2.
-
-
Very interesting paper from the FDA leadership on regulating AI in medicine. Some interesting points to note: 1) The FDA has not yet authorised any LLMs in medicine - if you are currently using them, you do so at your own professional risk with full liability. 2) The FDA acknowledges the risks of AI ambient scribes - hinting that these will indeed require regulating. 3) New frameworks will be required to assess LLMs - and the FDA suggests that we should start within clinical areas with the deepest body of research in low-risk settings to allow time for evaluation. 4) Very close post-market monitoring will be required - hospitals should not just be plugging in AI without an information ecosystem much like that monitoring a patient in the intensive care unit. Read the full paper here: https://lnkd.in/eAvABu5a
-
-
Is Digital Pathology the next frontier of health tech? NYU Langone may be the first major healthcare system to fully digitize its pathology data. Partnering with Philips Healthcare in a $115 million deal, it will leverage AI technology and interoperable platforms to convert cellular and tissue-level studies into high-quality images. These can be readily transferrable across clinical facilities, embed into the medical record, sidestep the issues of loss and deterioration (a constant risk with physical samples), and power AI-enabled solutions within the system. Find more about NYU Langone’s digital pathology program at the link below: https://lnkd.in/eRmrR4mx #pathology #digitalhealth #artificialintelligence #nyulangone Elizabeth Cho-Fertikh, PhD Tomas J. Philipson, Ph.D Carolyn Campbell Min Lang Tai Mai Laura Beken
NYU Langone Health Propels Disease Detection into the Digital Age
nyulangone.org
-
Bessemer Venture Partners recently released its “Roadmap” for healthcare AI, identifying the key drivers, pitfalls, and opportunities facing the nascent industry, alongside the firm’s general investment thesis. The report draws particular attention to multimodal AI tools - namely those synthesizing healthcare data from text, numerical, and imaging sources – as a powerhouse of future growth given the robustness of their input data and myriad downstream applications. It additionally identifies 20 verticals bearing > $1 billion TAM as priority investment targets, such as AI-enabled clinical trial development, revenue cycle management, evidence generation, and regulatory automation, among others. You can find the full report here: https://lnkd.in/gyetmccN #ai #digitalhealth #venturecapital #generativeai Elizabeth Cho-Fertikh, PhD Tomas J. Philipson, Ph.D Carolyn Campbell Min Lang Tai Mai Laura Beken
Roadmap: Healthcare AI
bvp.com
-
This. Our reason for being.
“The median multiple on invested capital for pharma deals led by specialist firms was 1.5x, versus 1.3x for generalists.” Specialists outperform generalists in most deeptech domains. Expertise and experience matter when things get more complex. https://lnkd.in/efJUkSN3
-
-
Here we go! It’s Noble Prize time!
BREAKING NEWS The Nobel Assembly at the Karolinska Institutet has today decided to award the 2024 Nobel Prize in Physiology or Medicine to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation. This year’s Nobel Prize honours two scientists for their discovery of a fundamental principle governing how gene activity is regulated. The information stored within our chromosomes can be likened to an instruction manual for all cells in our body. Every cell contains the same chromosomes, so every cell contains exactly the same set of genes and exactly the same set of instructions. Yet, different cell types, such as muscle and nerve cells, have very distinct characteristics. How do these differences arise? The answer lies in gene regulation, which allows each cell to select only the relevant instructions. This ensures that only the correct set of genes is active in each cell type. This year’s medicine laureates Victor Ambros and Gary Ruvkun were interested in how different cell types develop. They discovered microRNA, a new class of tiny RNA molecules that play a crucial role in gene regulation. Their groundbreaking discovery revealed a completely new principle of gene regulation that turned out to be essential for multicellular organisms, including humans. It is now known that the human genome codes for over one thousand microRNAs. Their surprising discovery revealed an entirely new dimension to gene regulation. MicroRNAs are proving to be fundamentally important for how organisms develop and function.
-